
betaBen - Building, selling, and fun.
Here you can read about me trying (sometimes failing) to build a business, my life thoughts, and interesting things that I'm creating.
betaBen - Fun
Here I mostly share posts about my personal projects or things I come across that I think are kind of cool (you probs won't unless you're a massive nerd too)
betaBen - Blog
I don't feel so good... Interested in seeing my "in progress" writing? Take a look here. Hi, I'm Ben! If you like what I write, subscribe below and I'll put it in your inbox when I post it. I won't send …
Florbetaben (18F) - Wikipedia
Florbetaben, sold under the brand name Neuraceq, is a diagnostic radiotracer developed for routine clinical application to visualize β-amyloid plaques in the brain. It is a fluorine-18 (18 F)-labeled stilbene derivative.
氟[¹⁸F]贝他苯(Florbetaben F-18) - 药物靶点:APP_在研适应症:阿 …
[18F]Florbetazine ( [18F]92) is a molecularly targeted imaging agent for Aβ protein with a novel diaryl-azine scaffold.
BetaBEN Video Demo - Exhibited at AWE 2024 (Narrated) - Vimeo
Don a pair of headphones and join Benvision CEO Patrick on a tour of BetaBEN's features at the Benvision Playground Booth in the expo hall of AWE (Augmented…
Beta-amyloid imaging with florbetaben - PMC
Florbetaben is a fluorine-18 (18 F)-labeled stilbene derivative that was developed as a positron emission tomography (PET) tracer for routine clinical application to visualize β-amyloid plaques in the Alzheimer’s disease (AD) brain.
Beta-amyloid imaging with florbetaben - PubMed
Florbetaben is a fluorine-18 (<sup>18</sup>F)-labeled stilbene derivative that was developed as a positron emission tomography (PET) tracer for routine clinical application to visualize β-amyloid plaques in the Alzheimer's disease (AD) brain. The tracer successfully completed a global multicenter ph …
betaBen
Currently exploring options, writing about it here >> betaben.com What are your KPIs? - Ideas killed (Goal: 37 by December 4th) - Ideas generated (Goal: 40 by November 27th)
Neuraceq | European Medicines Agency (EMA)
Neuraceq is a radiopharmaceutical indicated for Positron Emission Tomography (PET) imaging of ? amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment. Neuraceq should be used in conjunction with a clinical evaluation.
- 某些结果已被删除